Another limitation is we have inferred the effect of Abi3-Gngt2 deletion on Aβ and tau using independent, stand-alone models and thus, how this could affect AD phenotype, which is characterized by combinatorial Aβ and tau pathologies, still needs to be characterized. This evidence concerns the gene ABI3 and Alzheimer disease.